Literature DB >> 2266957

Role of fatty acid-binding protein in cardiac fatty acid oxidation.

N C Fournier1, M A Richard.   

Abstract

Although abundant in most biological tissues and chemically well characterized, the fatty acid-binding protein (FABP) was until recently in search of a function. Because of its strong affinity for long chain fatty acids and its cytoplasmic origin, this protein was repeatedly claimed in the literature to be the transcytoplasmic fatty acid carrier. However, techniques to visualize and quantify the movements of molecules in the cytoplasm are still in their infancy. Consequently the carrier function of FABP remains somewhat speculative. However, FABP binds not only fatty acids but also their CoA and carnitine derivatives, two typical molecules of mitochondrial origin. Moreover, it has been demonstrated and confirmed that FABP is not exclusively cytoplasmic, but also mitochondrial. A function for FABP in the mitochondrial metabolism of fatty acids plus CoA and carnitine derivatives would therefore be anticipated. Using spin-labelling techniques, we present here evidence that FABP is a powerful regulator of acylcarnitine flux entering the mitochondrial beta-oxidative system. In this perspective FABP appears to be an active link between the cytoplasm and the mitochondria, regulating the energy made available to the cell. This active participation of FABP is shown to be the consequence of its gradient-like distribution in the cardiac cell, and also of the coexistence of multispecies of this protein produced by self-aggregation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266957     DOI: 10.1007/bf00231379

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  11 in total

Review 1.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

Review 2.  Metabolism of the heart in health and disease. 3.

Authors:  L H Opie
Journal:  Am Heart J       Date:  1969-03       Impact factor: 4.749

Review 3.  Metabolism of the heart in health and disease. I.

Authors:  L H Opie
Journal:  Am Heart J       Date:  1968-11       Impact factor: 4.749

Review 4.  Metabolism of the heart in health and disease. II.

Authors:  L H Opie
Journal:  Am Heart J       Date:  1969-01       Impact factor: 4.749

5.  Phosphorylation coupled to acyl-coenzyme A dehydrogenase-linked oxidation of fatty acids by liver and heart mitochondria.

Authors:  J Bremer; E J Davis
Journal:  Biochim Biophys Acta       Date:  1972-09-20

6.  On rate-controlling factors of long chain fatty acid oxidation.

Authors:  S V Pande
Journal:  J Biol Chem       Date:  1971-09-10       Impact factor: 5.157

7.  Self-association of the cardiac fatty acid binding protein. Influence on membrane-bound, fatty acid dependent enzymes.

Authors:  N C Fournier; M Zuker; R E Williams; I C Smith
Journal:  Biochemistry       Date:  1983-04-12       Impact factor: 3.162

8.  Fatty acid-binding protein, a potential regulator of energy production in the heart. Investigation of mechanisms by electron spin resonance.

Authors:  N C Fournier; M A Richard
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

9.  Control of energy production in the heart: a new function for fatty acid binding protein.

Authors:  N C Fournier; M Rahim
Journal:  Biochemistry       Date:  1985-04-23       Impact factor: 3.162

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  13 in total

Review 1.  Historic overview of studies on fatty acid-binding proteins.

Authors:  R K Ockner
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

Review 2.  Cellular fatty acid-binding proteins: current concepts and future directions.

Authors:  J F Glatz; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

3.  Serum H-FABP levels in patients with hypothyroidism.

Authors:  Fahri Gunes; Mehmet Asik; Ahmet Temiz; Ahmet Vural; Hacer Sen; Emine Binnetoglu; Neslihan Bozkurt; Zeliha Tekeli; Gokhan Erbag; Kubilay Ukinc; Erdem Akbal
Journal:  Wien Klin Wochenschr       Date:  2014-09-19       Impact factor: 1.704

4.  Serum heart-type fatty acid binding protein levels in acromegaly patients.

Authors:  M Ozbek; M Erdogan; M Dogan; E Akbal; M A Ozturk; K Ureten
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

5.  New insights into intracellular lipid binding proteins: The role of buried water.

Authors:  Christian Lücke; Sinian Huang; Martin Rademacher; Heinz Rüterjans
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

6.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

7.  Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values.

Authors:  Cui Liyan; Zhang Jie; Hu Xiaozhou
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 8.  Replacement of vertebrate serum with lipids and other factors in the culture of invertebrate cells, tissues, parasites, and pathogens.

Authors:  R H Goodwin
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

9.  Serum heart type fatty acid binding protein levels in metabolic syndrome.

Authors:  Erdem Akbal; Mustafa Özbek; Fahri Güneş; Ömer Akyürek; Kemal Üreten; Tuncay Delibaşı
Journal:  Endocrine       Date:  2009-10-06       Impact factor: 3.633

10.  Prognostic value of prealbumin, N-terminal pro-B-type natriuretic peptide, heart type fatty acid binding protein, and cardiac troponin I in elderly patients for heart failure and poor outcomes.

Authors:  Shengzhuo Wang; Ketong Liu; Shoukun Guan; Ge Cui
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.